在日本慢性便秘的当前管理
1Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
The Keio journal of medicine
|August 23, 2023
概括
持续超过三个月的慢性便秘需要新的治疗算法. 虽然新疗法正在出现,但要有效管理耐火病例,需要采用标准化的方法.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 便秘是一种复杂的胃肠道疾病.
- 慢性便秘被定义为持续超过三个月的便秘.
- 目前的分类依赖于症状和病理生理学.
研究的目的:
- 突出需要治疗慢性便秘的治疗算法.
- 为弥补对传统药不耐用的便秘管理方面的差距.
主要方法:
- 审查日本最近批准的治疗剂.
- 对当前慢性便秘分类系统的分析.
主要成果:
- 日本已经批准了治疗慢性便秘的新疗法.
- 尽管获得了新的批准,但缺乏治疗算法.
- 知识和数据积累对于算法开发至关重要.
结论:
- 目前没有针对慢性便秘的综合治疗算法.
- 进一步的研究和数据收集对于制定有效的管理策略至关重要.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
206
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
206
Irritable Bowel Syndrome III: Medical and Nursing Management
240
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
240
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Inflammatory Bowel Disease V: Surgical Management
168
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
168
Drugs Affecting GI Tract Motility: Other Laxatives
273
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
273
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
247
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
247


